Literature DB >> 17389119

The public health aspects of bipolar disorder in children and adolescents.

Edith M Jolin1, Elizabeth B Weller, Ronald A Weller.   

Abstract

Bipolar disorder in children and adolescents is a major public health problem associated with significant functional impairment. Similar to adults with bipolar disorder, children and adolescents are at increased risk for substance-related disorders, weight problems, and impaired social support systems. Substance-related problems complicate treatment course. They often follow the onset of bipolar disorder; thus, the opportunity for prevention and/or early intervention exists. Evidence supports an association between mood disorders and weight gain. Psychotropic agents to treat bipolar disorder, particularly some second-generation antipsychotics, may be associated with weight gain. Obesity is associated with worse outcomes in bipolar disorder, so prevention of weight gain is clinically important. Environmental factors may contribute to relapse, so interventions to optimize social support systems are being evaluated. Pediatric bipolar disorder requires comprehensive management to achieve optimal outcome. Further research to study modifiable factors that contribute to its morbidity and chronicity is needed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389119     DOI: 10.1007/s11920-007-0079-6

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  59 in total

1.  Phenomenology and comorbidity of adolescents hospitalized for the treatment of acute mania.

Authors:  S A West; S M Strakowski; K W Sax; S L McElroy; P E Keck; B J McConville
Journal:  Biol Psychiatry       Date:  1996-03-15       Impact factor: 13.382

Review 2.  The psychosocial context of bipolar disorder: environmental, cognitive, and developmental risk factors.

Authors:  Lauren B Alloy; Lyn Y Abramson; Snezana Urosevic; Patricia D Walshaw; Robin Nusslock; Amy M Neeren
Journal:  Clin Psychol Rev       Date:  2005-09-06

3.  Changes in child and adolescent inpatient psychiatric admission diagnoses between 1995 and 2000.

Authors:  Ilan Harpaz-Rotem; Douglas L Leslie; Andres Martin; Robert A Rosenheck
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-08-18       Impact factor: 4.328

4.  Prevalence of overweight and obesity in bipolar patients.

Authors:  J L Elmslie; J T Silverstone; J I Mann; S M Williams; S E Romans
Journal:  J Clin Psychiatry       Date:  2000-03       Impact factor: 4.384

5.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

6.  Psychosocial functioning in a prepubertal and early adolescent bipolar disorder phenotype.

Authors:  B Geller; K Bolhofner; J L Craney; M Williams; M P DelBello; K Gundersen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-12       Impact factor: 8.829

7.  Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania.

Authors:  Mani N Pavuluri; David B Henry; Julie A Carbray; Gwendolyn Sampson; Michael W Naylor; Philip G Janicak
Journal:  J Affect Disord       Date:  2004-10       Impact factor: 4.839

8.  Combination lithium and divalproex sodium in pediatric bipolarity.

Authors:  Robert L Findling; Nora K McNamara; Barbara L Gracious; Eric A Youngstrom; Robert J Stansbrey; Michael D Reed; Christine A Demeter; Lisa A Branicky; Kathryn E Fisher; Joseph R Calabrese
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-08       Impact factor: 8.829

9.  Bipolar disorder and comorbid conduct disorder in childhood and adolescence.

Authors:  M Kovacs; M Pollock
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1995-06       Impact factor: 8.829

10.  Clozapine in adolescent inpatients with acute mania.

Authors:  Gabriele Masi; Maria Mucci; Stefania Millepiedi
Journal:  J Child Adolesc Psychopharmacol       Date:  2002       Impact factor: 2.576

View more
  3 in total

1.  A brief motivational intervention for preventing medication-associated weight gain among youth with bipolar disorder: treatment development and case report.

Authors:  Tina R Goldstein; Benjamin I Goldstein; Michael B Mantz; Bridget Bailey; Antoine Douaihy
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-06       Impact factor: 2.576

Review 2.  Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review.

Authors:  José María Martínez-Ortega; Silvia Funes-Godoy; Francisco Díaz-Atienza; Luis Gutiérrez-Rojas; Lucía Pérez-Costillas; Manuel Gurpegui
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-03-17       Impact factor: 4.785

3.  Treatment use and costs among privately insured youths with diagnoses of bipolar disorder.

Authors:  Stacie B Dusetzina; Joel F Farley; Morris Weinberger; Bradley N Gaynes; Betsy Sleath; Richard A Hansen
Journal:  Psychiatr Serv       Date:  2012-10       Impact factor: 3.084

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.